Drugs

Hansa Biopharma, an innovative commercial biopharmaceutical entity, together with Genethon, a leader in the sphere of gene therapy for rare genetic disorders, announced the launch of GNT-018-IDES. This is a phase 2 clinical trial aimed at individuals with Crigler-Najjar syndrome […]

India is observing an unexpected surge in lung cancer cases among individuals who have never smoked, challenging traditional views and causing concern within the medical field. Dr. Aravind Badiger, the technical director of BDR Pharmaceuticals, highlights this trend as a

The Consortium of the All India Pharmaceutical Association (AIPAC), in collaboration with the Society for Pharmaceutical Dissolution Science (SPDS) and the Indian Pharmaceutical Manufacturers Association’s Madhya Pradesh division (MP IDMA), will be hosting a one-day symposium focused on ‘Dissolution Science

The Karnataka government has named BP Arun, the Deputy Drug Controller at the Mysuru regional office, as the latest authority for licensing, controlling, and approving in the state’s drug control department. Arun steps in as the successor to Dr. Umesh

MediBuddy has unveiled the India Health Care Collaborators (IHCC), a platform designed to bring together insurance companies, brokers, and healthcare providers. This initiative is focused on enhancing access to a secure, cashless primary healthcare system. The new platform, called BuddyCare,

**Swedish Innovator Nyctea Technologies Seeks Growth in Drug Purification Technologies** Nyctea Technologies, a Swedish startup focused on both deeptech and medtech, is setting its sights on expanding into new markets with its pioneering biomolecular purification system. Originating as a project

Medexus Pharmaceuticals, recognized as a prominent specialty pharmaceutical company with a robust North American presence and an expanding range of unique treatments for rare disorders, recently declared that it has reached a fourth amendment to its exclusive licensing agreement from

Eppendorf SE, a renowned leader in the life sciences sector, has joined forces with DataHow AG, an innovator in advanced data analytics and AI-driven prediction software, to announce a strategic collaboration aimed at revolutionizing bioprocess development. This partnership will allow

Senti Biosciences, Inc., a biotechnology firm currently in the clinical-stage, is advancing innovative cell and gene therapies via its unique gene circuit platform. The company has finalized a securities purchase agreement, permitting select existing and new accredited investors to purchase

Ainos Inc, a pioneering healthcare firm based in San Diego that specializes in advanced AI-enhanced point-of-care diagnostics and low-dose interferon therapies, has disclosed that it has entered into a crucial memorandum of understanding (MoU) with Taiwan Tanabe Seiyaku Co, Ltd.